Archive for the ‘jacc’ Category
Two American College of Cardiology conference abstracts published earlier this year in the Journal of the American College of Cardiology (JACC) have been retracted, one because the authors were actually measuring something other than what they reported, and the other because newer software invalidated the results.
Here’s the notice for “Worsening of Pre-Existing Valvulopathy With A New Obesity Drug Lorcaserin, A Selective 5-Hydroxytryptamine 2C Receptor Agonist: A Meta-Analysis of Randomized Controlled Trials” by Hemang B. Panchal, Parthav Patel, Brijal Patel, Rakeshkumar Patel, and Henry Philip of East Tennessee State University: Read the rest of this entry »
The two notices, for “Prediction of cardiovascular events in statin-treated patients by lipid and non-lipid biomarkers” and “Plasma PCSK9 levels and clinical outcomes in the TNT (Treating to New Targets) Trial,” are highly detailed and say the same thing: Read the rest of this entry »
The Journal of the American College of Cardiology, or JACC, has issued expressions of concern for three papers by Don Poldermans, the Dutch cardiologist who was fired earlier this year amid allegations of misconduct.
Cardiobrief’s Larry Husten had the story first.
The, um, heart of the matter is that neither the investigators at Erasmus Medical Center, Poldermans’ former institution, nor the JACC editors, can say whether the researchers conduct rose to the level of fabricating data. As the Notice of Concern states: Read the rest of this entry »
Not for the faint of heart: Cardiologists retract syncope paper after realizing data columns weren’t aligned right
The paper originally concluded that fainting spells (syncope) give patients with high blood pressure in their lung arteries poor prognoses, an observation that turned out to be incorrect.
The problem? The group merged two electronic databases, but did not align columns properly, a problem found only after first author Rachel Le revisited the dataset looking to cull more data.